🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The treatment efficacy for stage IVb esophageal cancer has been improved th...
Status
Recruiting
Location
Cancer hospital, CAMS
Start Date
2024-02-04
Trial ID
NCT06086457
Treatments Being Tested
The main aim of this study is to compare the efficacy of short-course versu...
Status
Active Not Recruiting
Location
Oncologia Medica e Prevenzione Oncologica Centro di riferimento oncologico (CRO), IRCCS
Start Date
2020-11-03
Trial ID
NCT04793932
Treatments Being Tested
This is a multi-center, prospective and observational clinical study. Eligi...
Status
Completed
Location
Lin Shen
Start Date
2011-11
Trial ID
NCT01472250
Treatments Being Tested
An Open-label, Multicenter, Phase II Clinical Study to Evaluate the Efficac...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2026-02-26
Trial ID
NCT07331155
The efficacy of HIPEC in prevention of local recurrence, distant metastasis...
Status
Completed
Location
Zhongnan Hospital of Wuhan University
Start Date
2016-07
Trial ID
NCT02830139
To determine the best dose of this investigational agent AG-013736 in combi...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-12
Trial ID
NCT00454649
Treatments Being Tested
The primary objectives of this study were: to assess the safety and tolerab...
Status
Completed
Location
Mayo Clinic Phoenix
Start Date
2019-08-15
Trial ID
NCT04047862
The objective of this study is to assess the reproducibility of PAXG regime...
Status
Unknown
Location
IRCCS Centro di Riferimento Oncologico (CRO)
Start Date
2020-07-08
Trial ID
NCT04480268
Treatments Being Tested
This study plans to enroll 156 patients aged 18-75, who will be randomly di...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-18
Trial ID
NCT07191405
Treatments Being Tested
Open label multicentric phase II randomized trial, using high throughput ge...
Status
Active Not Recruiting
Location
Institut de Cancérologie de l'Ouest/Paul Papin
Start Date
2014-04-07
Trial ID
NCT02299999